{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,26]],"date-time":"2026-09-26T04:52:13Z","timestamp":1790398333333,"version":"4.1.0"},"reference-count":44,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,9,26]],"date-time":"2025-09-26T00:00:00Z","timestamp":1758844800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,9,26]],"date-time":"2025-09-26T00:00:00Z","timestamp":1758844800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100001711","name":"Schweizerischer Nationalfonds zur F\u00f6rderung der Wissenschaftlichen Forschung","doi-asserted-by":"publisher","award":["33IC30_221622"],"award-info":[{"award-number":["33IC30_221622"]}],"id":[{"id":"10.13039\/501100001711","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100008375","name":"University of Basel","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100008375","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Trials"],"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:sec>\n            <jats:title>Background<\/jats:title>\n            <jats:p>A frequent and increasing indication for liver transplantation (LT) is hepatocellular carcinoma (HCC). However, despite strict selection criteria, HCC recurrence after LT occurs in a relevant proportion of patients and is associated with an unfavorable prognosis. Hypothermic oxygenated perfusion (HOPE) is a novel machine liver perfusion approach to optimize liver grafts before implantation and has been suggested to decrease graft inflammation with potential anti-cancer effects.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Methods<\/jats:title>\n            <jats:p>HOPE4Cancer is an international, multicentric, parallel group, randomized controlled trial comparing HOPE performed after initial cold storage (intervention) with conventional cold storage alone (control) in a 1:1 allocation ratio. Adult recipients with proven HCC will be included for transplantation of a DBD (donation after brain death) Liver graft. The minimum perfusion duration is defined at 2\u00a0h and perfusion is generally continued until the recipient hepatectomy is completed. The conventional cold storage at 4\u00a0\u00b0C will be performed with a precooled preservation solution according to the local standard of care. The primary endpoint is defined as post-transplant HCC recurrence-free survival, i.e., the time interval a patient is alive without HCC recurrence after transplantation. Secondary endpoints are the single components of the events considered for the primary outcome (i.e., HCC recurrence, HCC-related death, death from any other causes than HCC), circulating tumor DNA, high-mobility-group-protein B1 in the blood, the Rejection Activity index, and the number of liver-related complications experienced by the patient.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Discussion<\/jats:title>\n            <jats:p>HOPE4Cancer investigates if cold storage plus end-ischemically applied HOPE in DBD LT is superior to conventional cold storage of liver grafts in terms of post-transplant HCC recurrence-free survival. The results will indicate for the first time whether ex situ HOPE before transplant has an anti-cancer potential compared to transplantation of un-perfused livers.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Trial registration<\/jats:title>\n            <jats:p>ClinicalTrials.gov NCT06717919. Registered on December 5, 2024.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1186\/s13063-025-09120-1","type":"journal-article","created":{"date-parts":[[2025,9,26]],"date-time":"2025-09-26T10:41:58Z","timestamp":1758883318000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Hypothermic oxygenated perfusion (HOPE) against cancer recurrence after liver transplantation for hepatocellular carcinoma\u2014study protocol for an international multicenter randomized controlled trial (HOPE4Cancer)"],"prefix":"10.1186","volume":"26","author":[{"given":"Janina","family":"Eden","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philip C.","family":"M\u00fcller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christoph","family":"Kuemmerli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Florian","family":"Peters","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tanja","family":"Litke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anne","family":"Kranich","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andreas E.","family":"Kremer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefanie","family":"von Felten","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philipp","family":"Dutkowski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"name":"HOPE4Cancer Trial Investigators","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vincent E","family":"de Meijer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lutz","family":"Fischer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Umberto","family":"Cillo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Riccardo","family":"De Carlis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vincenzo","family":"Mazzaferro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert J","family":"Porte","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jacques","family":"Pirenne","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea","family":"Schlegel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James V","family":"Guarrera","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gabriela","family":"Berlakovich","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiri","family":"Fronek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Georg","family":"Lurje","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jens","family":"Mittler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Moritz","family":"Drefs","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philippe","family":"Compagnon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miriam","family":"Cortes-Cerisuelo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joerg M","family":"Pollok","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Barbara","family":"Fiore","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rebeca","family":"Sanabria-Mateos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christoph","family":"Tschuor","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cornelius","family":"van Beekum","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ulf P","family":"Neumann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gabriel C","family":"Oniscu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Povilas","family":"Ignatavicius","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xavier","family":"Muller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Diethard","family":"Monbaliu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefan","family":"Schneeberger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Piotr","family":"Domagala","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P\u00e5l-Dag","family":"Line","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Umberto","family":"Baccarani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eliano","family":"Bonaccorsi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rodrigo","family":"Figueiredo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philipp","family":"Kron","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,9,26]]},"reference":[{"key":"9120_CR1","doi-asserted-by":"publisher","first-page":"e11","DOI":"10.1016\/S1470-2045(11)70175-9","volume":"13","author":"PA Clavien","year":"2012","unstructured":"Clavien PA, Lesurtel M, Bossuyt PM, Gores GJ, Langer B, Perrier A. Recommendations for liver transplantation for hepatocellular carcinoma: an international consensus conference report. Lancet Oncol. 2012;13:e11-22.","journal-title":"Lancet Oncol"},{"key":"9120_CR2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejso.2024.107952","volume":"50","author":"M Drefs","year":"2024","unstructured":"Drefs M, Schoenberg MB, B\u00f6rner N, Koliogiannis D, Koch DT, Schirren MJ, et al. Changes of long-term survival of resection and liver transplantation in hepatocellular carcinoma throughout the years: a meta-analysis. Eur J Surg Oncol. 2024;50:107952.","journal-title":"Eur J Surg Oncol"},{"key":"9120_CR3","doi-asserted-by":"publisher","DOI":"10.1111\/liv.16178","volume":"45","author":"CTJ Magyar","year":"2025","unstructured":"Magyar CTJ, Arteaga NF, Germani G, Karam VH, Adam R, Romagnoli R, et al. Recipient-donor sex constellation in liver transplantation for hepatocellular carcinoma-an ELTR study. Liver Int. 2025;45:e16178.","journal-title":"Liver Int"},{"issue":"6","key":"9120_CR4","doi-asserted-by":"publisher","first-page":"1398","DOI":"10.1016\/j.jhep.2020.12.021","volume":"74","author":"D Goldberg","year":"2021","unstructured":"Goldberg D, Mantero A, Newcomb C, Delgado C, Forde KA, Kaplan DE, et al. Predicting survival after liver transplantation in patients with hepatocellular carcinoma using the LiTES-HCC score. J Hepatol. 2021;74(6):1398\u2013406.","journal-title":"J Hepatol"},{"key":"9120_CR5","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1016\/S1470-2045(08)70284-5","volume":"10","author":"V Mazzaferro","year":"2009","unstructured":"Mazzaferro V, Llovet JM, Miceli R, Bhoori S, Schiavo M, Mariani L, et al. Predicting survival after liver transplantation in patients with hepatocellular carcinoma beyond the Milan criteria: a retrospective, exploratory analysis. Lancet Oncol. 2009;10:35\u201343.","journal-title":"Lancet Oncol"},{"key":"9120_CR6","doi-asserted-by":"publisher","DOI":"10.3390\/ijms23179747","author":"A Parente","year":"2022","unstructured":"Parente A, Flores Carvalho M, Eden J, Dutkowski P, Schlegel A. Mitochondria and cancer recurrence after liver transplantation-what is the benefit of machine perfusion? Int J Mol Sci. 2022. https:\/\/doi.org\/10.3390\/ijms23179747.","journal-title":"Int J Mol Sci"},{"key":"9120_CR7","doi-asserted-by":"publisher","first-page":"2665","DOI":"10.1097\/TP.0000000000001844","volume":"101","author":"CX Li","year":"2017","unstructured":"Li CX, Man K, Lo CM. The impact of liver graft injury on cancer recurrence posttransplantation. Transplantation. 2017;101:2665\u201370.","journal-title":"Transplantation"},{"key":"9120_CR8","doi-asserted-by":"publisher","DOI":"10.1155\/2014\/409272","volume":"2014","author":"D Luo","year":"2014","unstructured":"Luo D, Wang Z, Wu J, Jiang C, Wu J. The role of hypoxia inducible factor-1 in hepatocellular carcinoma. Biomed Res Int. 2014;2014:409272.","journal-title":"Biomed Res Int"},{"key":"9120_CR9","first-page":"461","volume":"40","author":"M Jiao","year":"2012","unstructured":"Jiao M, Nan KJ. Activation of PI3 kinase\/Akt\/HIF-1\u03b1 pathway contributes to hypoxia-induced epithelial-mesenchymal transition and chemoresistance in hepatocellular carcinoma. Int J Oncol. 2012;40:461\u20138.","journal-title":"Int J Oncol"},{"key":"9120_CR10","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1038\/cr.2010.183","volume":"21","author":"G He","year":"2011","unstructured":"He G, Karin M. NF-\u03baB and STAT3 - key players in liver inflammation and cancer. Cell Res. 2011;21:159\u201368.","journal-title":"Cell Res"},{"key":"9120_CR11","doi-asserted-by":"publisher","first-page":"1","DOI":"10.4103\/jcar.JCar_9_16","volume":"16","author":"YA Ghouri","year":"2017","unstructured":"Ghouri YA, Mian I, Rowe JH. Review of hepatocellular carcinoma: epidemiology, etiology, and carcinogenesis. J Carcinog. 2017;16:1.","journal-title":"J Carcinog"},{"key":"9120_CR12","doi-asserted-by":"publisher","first-page":"1201","DOI":"10.1016\/j.jhep.2023.05.027","volume":"79","author":"A Parente","year":"2023","unstructured":"Parente A, Tirotta F, Pini A, Eden J, Dondossola D, Manzia TM, et al. Machine perfusion techniques for liver transplantation - a meta-analysis of the first seven randomized-controlled trials. J Hepatol. 2023;79:1201\u201313.","journal-title":"J Hepatol"},{"key":"9120_CR13","doi-asserted-by":"publisher","first-page":"1330","DOI":"10.1016\/j.jhep.2022.01.024","volume":"76","author":"A Schlegel","year":"2022","unstructured":"Schlegel A, Porte RJ, Dutkowski P. Protective mechanisms and current clinical evidence of hypothermic oxygenated machine perfusion (HOPE) in preventing post-transplant cholangiopathy. J Hepatol. 2022;76:1330\u201347.","journal-title":"J Hepatol"},{"key":"9120_CR14","doi-asserted-by":"publisher","first-page":"759","DOI":"10.1097\/SLA.0000000000004258","volume":"272","author":"M Mueller","year":"2020","unstructured":"Mueller M, Kalisvaart M, O\u2019Rourke J, Shetty S, Parente A, Muller X, et al. Hypothermic oxygenated liver perfusion (HOPE) prevents tumor recurrence in liver transplantation from donation after circulatory death. Ann Surg. 2020;272:759\u201365.","journal-title":"Ann Surg"},{"key":"9120_CR15","doi-asserted-by":"crossref","unstructured":"Kron P, Schlegel A, Mancina L, Clavien PA, Dutkowski P. Hypothermic oxygenated perfusion (HOPE) for fatty liver grafts in rats and humans. J Hepatol 2017.","DOI":"10.1016\/j.jhep.2017.08.028"},{"key":"9120_CR16","doi-asserted-by":"publisher","first-page":"619","DOI":"10.1111\/aor.14715","volume":"48","author":"G Dajti","year":"2024","unstructured":"Dajti G, Germinario G, Prosperi E, Siniscalchi A, Vasuri F, Valente S, et al. The role of cold ischemia time and hypothermic perfusion in predicting early hepatocellular carcinoma recurrences after liver transplantation. Artif Organs. 2024;48:619\u201325.","journal-title":"Artif Organs"},{"key":"9120_CR17","doi-asserted-by":"publisher","DOI":"10.3390\/jpm13050703","author":"F Rigo","year":"2023","unstructured":"Rigo F, De Stefano N, Patrono D, De Donato V, Campi L, Turturica D, et al. Impact of hypothermic oxygenated machine perfusion on hepatocellular carcinoma recurrence after liver transplantation. J Pers Med. 2023. https:\/\/doi.org\/10.3390\/jpm13050703.","journal-title":"J Pers Med"},{"key":"9120_CR18","doi-asserted-by":"publisher","first-page":"783","DOI":"10.1016\/j.jhep.2022.12.030","volume":"78","author":"A Schlegel","year":"2023","unstructured":"Schlegel A, Mueller M, Muller X, Eden J, Panconesi R, von Felten S, et al. A multicenter randomized-controlled trial of hypothermic oxygenated perfusion (HOPE) for human liver grafts before transplantation. J Hepatol. 2023;78:783\u201393.","journal-title":"J Hepatol"},{"key":"9120_CR19","doi-asserted-by":"publisher","first-page":"1391","DOI":"10.1056\/NEJMoa2031532","volume":"384","author":"R van Rijn","year":"2021","unstructured":"van Rijn R, Schurink IJ, de Vries Y, van den Berg AP, Cortes Cerisuelo M, Darwish Murad S, et al. Hypothermic machine perfusion in liver transplantation - a randomized trial. N Engl J Med. 2021;384:1391\u2013401.","journal-title":"N Engl J Med"},{"key":"9120_CR20","doi-asserted-by":"publisher","first-page":"2401","DOI":"10.1111\/ajt.17115","volume":"22","author":"M Ravaioli","year":"2022","unstructured":"Ravaioli M, Germinario G, Dajti G, Sessa M, Vasuri F, Siniscalchi A, et al. Hypothermic oxygenated perfusion in extended criteria donor liver transplantation-a randomized clinical trial. Am J Transplant. 2022;22:2401\u20138.","journal-title":"Am J Transplant"},{"key":"9120_CR21","doi-asserted-by":"publisher","DOI":"10.1097\/TXD.0000000000001184","volume":"7","author":"Y de Vries","year":"2021","unstructured":"de Vries Y, Br\u00fcggenwirth IMA, Karangwa SA, von Meijenfeldt FA, van Leeuwen OB, Burlage LC, et al. Dual versus single oxygenated hypothermic machine perfusion of porcine livers: impact on hepatobiliary and endothelial cell injury. Transplant Direct. 2021;7:e741.","journal-title":"Transplant Direct"},{"key":"9120_CR22","doi-asserted-by":"publisher","first-page":"13891","DOI":"10.3389\/ti.2025.13891","volume":"38","author":"DT Koch","year":"2025","unstructured":"Koch DT, Tamai M, Schirren M, Drefs M, Jacobi S, Lange CM, et al. Mono-HOPE versus dual-HOPE in liver transplantation: a propensity score-matched evaluation of early graft outcome. Transpl Int. 2025;38:13891.","journal-title":"Transpl Int"},{"key":"9120_CR23","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1016\/j.jhep.2024.06.035","volume":"82","author":"J Eden","year":"2025","unstructured":"Eden J, Br\u00fcggenwirth IMA, Berlakovich G, Buchholz BM, Botea F, Camagni S, et al. Long-term outcomes after hypothermic oxygenated machine perfusion and transplantation of 1,202 donor livers in a real-world setting (HOPE-REAL study). J Hepatol. 2025;82:97\u2013106.","journal-title":"J Hepatol"},{"key":"9120_CR24","doi-asserted-by":"publisher","DOI":"10.1016\/j.eclinm.2023.102411","volume":"68","author":"IMA Br\u00fcggenwirth","year":"2024","unstructured":"Br\u00fcggenwirth IMA, Lantinga VA, Lascaris B, Thorne AM, Meerdink M, de Kleine RH, et al. Prolonged hypothermic machine perfusion enables daytime liver transplantation - an IDEAL stage 2 prospective clinical trial. eClinicalMedicine. 2024;68:102411.","journal-title":"eClinicalMedicine"},{"key":"9120_CR25","doi-asserted-by":"publisher","first-page":"1842","DOI":"10.1111\/ajt.17037","volume":"22","author":"IMA Br\u00fcggenwirth","year":"2022","unstructured":"Br\u00fcggenwirth IMA, Mueller M, Lantinga VA, Camagni S, De Carlis R, De Carlis L, et al. Prolonged preservation by hypothermic machine perfusion facilitates logistics in liver transplantation: a European observational cohort study. Am J Transplant. 2022;22:1842\u201351.","journal-title":"Am J Transplant"},{"key":"9120_CR26","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1053\/j.gastro.2017.09.025","volume":"154","author":"V Mazzaferro","year":"2018","unstructured":"Mazzaferro V, Sposito C, Zhou J, Pinna AD, De Carlis L, Fan J, et al. Metroticket 2.0 model for analysis of competing risks of death after liver transplantation for hepatocellular carcinoma. Gastroenterology. 2018;154:128\u201339.","journal-title":"Gastroenterology"},{"key":"9120_CR27","doi-asserted-by":"publisher","first-page":"2014","DOI":"10.1002\/hep.31210","volume":"72","author":"A Kardashian","year":"2020","unstructured":"Kardashian A, Florman SS, Haydel B, Ruiz RM, Klintmalm GB, Lee DD, et al. Liver transplantation outcomes in a U.S. multicenter cohort of 789 patients with hepatocellular carcinoma presenting beyond Milan criteria. Hepatology. 2020;72:2014\u201328.","journal-title":"Hepatology"},{"key":"9120_CR28","doi-asserted-by":"publisher","first-page":"2818","DOI":"10.1097\/JS9.0000000000001104","volume":"110","author":"CJ Wehrle","year":"2024","unstructured":"Wehrle CJ, Raj R, Maspero M, Satish S, Eghtesad B, Pita A, et al. Risk assessment in liver transplantation for hepatocellular carcinoma: long-term follow-up of a two-centre experience. Int J Surg. 2024;110:2818\u201331.","journal-title":"Int J Surg"},{"key":"9120_CR29","doi-asserted-by":"publisher","first-page":"507","DOI":"10.2307\/2531201","volume":"42","author":"JM Lachin","year":"1986","unstructured":"Lachin JM, Foulkes MA. Evaluation of sample size and power for analyses of survival with allowance for nonuniform patient entry, losses to follow-up, noncompliance, and stratification. Biometrics. 1986;42:507\u201319.","journal-title":"Biometrics"},{"key":"9120_CR30","doi-asserted-by":"publisher","first-page":"1219","DOI":"10.1002\/bimj.202100085","volume":"64","author":"KM Anderson","year":"2022","unstructured":"Anderson KM, Guo Z, Zhao J, Sun LZ. A unified framework for weighted parametric group sequential design. Biom J. 2022;64:1219\u201339.","journal-title":"Biom J"},{"key":"9120_CR31","unstructured":"R Core Team (2023). R: a language and environment for statistical computing. R Foundation for Statistical Computing, Vienna, Austria. URL https:\/\/www.R-project.org\/."},{"key":"9120_CR32","unstructured":"Snow G, Snow M. Package \u201cblockrand.\u201d The comprehensive R archive network. 2013. In; 2020."},{"key":"9120_CR33","unstructured":"Therneau TM (2022). coxme: mixed effects cox models. R package version 2.2-18.1. URL https:\/\/CRAN.R-project.org\/package=coxme"},{"key":"9120_CR34","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1002\/pst.1612","volume":"13","author":"M Munda","year":"2014","unstructured":"Munda M, Legrand C. Adjusting for centre heterogeneity in multicentre clinical trials with a time-to-event outcome. Pharm Stat. 2014;13:145\u201352.","journal-title":"Pharm Stat"},{"key":"9120_CR35","doi-asserted-by":"publisher","DOI":"10.32614\/RJ-2021-075","author":"B Tam\u00e1si","year":"2021","unstructured":"Tam\u00e1si B, Hothorn T. tramME: mixed-effects transformation models using Template Model Builder. R J. 2021. https:\/\/doi.org\/10.32614\/RJ-2021-075.","journal-title":"R J"},{"key":"9120_CR36","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1186\/s12874-020-00984-2","volume":"20","author":"M Buri","year":"2020","unstructured":"Buri M, Curt A, Steeves J, Hothorn T. Baseline-adjusted proportional odds models for the quantification of treatment effects in trials with ordinal sum score outcomes. BMC Med Res Methodol. 2020;20:104.","journal-title":"BMC Med Res Methodol"},{"key":"9120_CR37","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1002\/pst.516","volume":"11","author":"S Todd","year":"2012","unstructured":"Todd S, Vald\u00e9s-M\u00e1rquez E, West J. A practical comparison of blinded methods for sample size reviews in survival data clinical trials. Pharm Stat. 2012;11:141\u20138.","journal-title":"Pharm Stat"},{"key":"9120_CR38","doi-asserted-by":"publisher","first-page":"376","DOI":"10.1177\/0962280220948550","volume":"30","author":"K Hemming","year":"2021","unstructured":"Hemming K, Hughes JP, McKenzie JE, Forbes AB. Extending the I-squared statistic to describe treatment effect heterogeneity in cluster, multi-centre randomized trials and individual patient data meta-analysis. Stat Methods Med Res. 2021;30:376\u201395.","journal-title":"Stat Methods Med Res"},{"key":"9120_CR39","unstructured":"ICH E9 (R1) (2020). Addendum on estimands and sensitivity analysis in clinical trials to the guideline on statistical principles for clinical trials. Tech. Rep. Step 5 (17 February 2020). https:\/\/www.ema.europa.eu\/en\/documents\/scientific-guideline\/ich-e9-r1-addendum-estimands-sensitivity-analysis-clinical-trials-guideline-statistical-principles_en.pdf."},{"key":"9120_CR40","doi-asserted-by":"publisher","DOI":"10.1038\/sdata.2016.18","volume":"3","author":"MD Wilkinson","year":"2016","unstructured":"Wilkinson MD, Dumontier M, Aalbersberg IJ, Appleton G, Axton M, Baak A, et al. The FAIR guiding principles for scientific data management and stewardship. Sci Data. 2016;3:160018.","journal-title":"Sci Data"},{"key":"9120_CR41","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhepr.2023.100846","volume":"5","author":"M Maspero","year":"2023","unstructured":"Maspero M, Yilmaz S, Cazzaniga B, Raj R, Ali K, Mazzaferro V, et al. The role of ischaemia-reperfusion injury and liver regeneration in hepatic tumour recurrence. JHEP Rep. 2023;5:100846.","journal-title":"JHEP Rep"},{"key":"9120_CR42","doi-asserted-by":"publisher","first-page":"8935","DOI":"10.1038\/s41598-018-27319-y","volume":"8","author":"M Gr\u0105t","year":"2018","unstructured":"Gr\u0105t M, Krawczyk M, Wronka KM, Stypu\u0142kowski J, Lewandowski Z, Wasilewicz M, et al. Ischemia-reperfusion injury and the risk of hepatocellular carcinoma recurrence after deceased donor liver transplantation. Sci Rep. 2018;8:8935.","journal-title":"Sci Rep"},{"key":"9120_CR43","doi-asserted-by":"publisher","first-page":"895","DOI":"10.1002\/hep.27358","volume":"61","author":"S Nagai","year":"2015","unstructured":"Nagai S, Yoshida A, Facciuto M, Moonka D, Abouljoud MS, Schwartz ME, et al. Ischemia time impacts recurrence of hepatocellular carcinoma after liver transplantation. Hepatology. 2015;61:895\u2013904.","journal-title":"Hepatology"},{"key":"9120_CR44","doi-asserted-by":"publisher","first-page":"2832","DOI":"10.1007\/s10620-015-3541-z","volume":"60","author":"A Kornberg","year":"2015","unstructured":"Kornberg A, Witt U, Kornberg J, Friess H, Thrum K. Extended ischemia times promote risk of HCC recurrence in liver transplant patients. Dig Dis Sci. 2015;60:2832\u20139.","journal-title":"Dig Dis Sci"}],"container-title":["Trials"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13063-025-09120-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13063-025-09120-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13063-025-09120-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,26]],"date-time":"2025-09-26T10:42:01Z","timestamp":1758883321000},"score":1,"resource":{"primary":{"URL":"https:\/\/trialsjournal.biomedcentral.com\/articles\/10.1186\/s13063-025-09120-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9,26]]},"references-count":44,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["9120"],"URL":"https:\/\/doi.org\/10.1186\/s13063-025-09120-1","relation":{},"ISSN":["1745-6215"],"issn-type":[{"value":"1745-6215","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,9,26]]},"assertion":[{"value":"28 April 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 August 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 September 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The ethics committees of Vienna. Innsbruck, Prague, and Stockholm approved the study (2229\/2024, 1091\/2025, 03775\/25, 2025-02-12), ethics for all other sites are currently submitted. Written, informed consent to participate will be obtained from all participants.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate {24}"}},{"value":"Not applicable","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication {32}"}},{"value":"There are no competing interests","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests {28}"}}],"article-number":"369"}}